Dr. Nguyen Thi Ngoc Tram - Director of Thien Duoc Co., Ltd informed that Crila product formulated from Crinum latifolium L. of Thien Duoc company was licensed for circulation as the treatment for uterine fibroids and benign prostatic hyperplasia. Recently, Crila has been one of three products approved to be the national drug product that was enhanced the investment in research and large-scale production by the Ministry of Health. Currently, another product of the company formulated from Crinum latifolium L. continues to be studied for its ability to support cancer treatment. This research project is a collaboration of scientists from Bulgaria and Austria, and is currently in the research phase in vitro and in vivo.

 

LIEN CHAU - NGOC THANG